Alison Urton

[CCTG @CDNCancerTrials]

Trial was conducted by the Canadian Cancer Trials Group #CCTG with co-leads Dr Christopher Booth and Dr Kerry Courneya and made possible through the support of the Canadian Cancer Society. @cancersociety

[Bishal Gyawali, MD, PhD, FASCO @oncology_bg]

Such a well deserved standing ovation for Chris Booth and the Challenge trial. These data are quite powerful. Much stronger evidence than what we saw in plenaries today. #ASCO25

[CCTG @CDNCancerTrials]

The #CO21 CHALLENGE trial results were presented today at #ASCO25 annual meeting - the groundbreaking study is the first to conclusively answer a long-standing question in oncology: Can physical activity improve cancer survival? https://t.co/X6uFtNgzyz

[Sharlene Gill, MD, MPH, MBA, FASCO @GillSharlene]

#ASCO25 @ASCO @NEJM
✅ Exercise Saves Lives After Colon Cancer

➡️ come watch Dr Chris Booth present the results of the ph3 CO.21 CHALLENGE study - don’t walk, run! 🏃🏃🏻‍♂️🏃
Hall B1 430-6pm

🙏 to our patients, my GI group @CDNCancerTrials 🇨🇦 and our partner @GICancer 🇦🇺🇳🇿for sticking with this trial over the past 15 years!
#trialsthatmatter

[CCTG @CDNCancerTrials]

The #CCTG MA40 FINER clinical trial presented at #ASCO25 shows promise in slowing advanced breast cancer progression https://t.co/LnXnhhPPJs @Roche @BCTrialsANZ

[CCTG @CDNCancerTrials]

Please help us reach our fundraising goal for #RelayForLife at Queen's University. A donation of $25, $50 or $100 helps make sure researchers have the resources to make a life-saving discoveries or a patient has access to support services. #RelayForLife
https://t.co/jTpWuU4YCc

[Research at Canadian Cancer Society @CCSResearch]

We’re thrilled to support this groundbreaking clinical trial on how palliative radiation can improve quality of life for people with liver cancer. Congratulations to the researchers and @CDNCancerTrials on the publication of these results in @TheLancetOncol. #cancerresearch

[CCTG @CDNCancerTrials]

The biennial New Investigator Clinical Trials Course #NICTC2024 was kicked off this morning with an EDIIA session discussing upcoming strategies for new trials. #SolvingCancerTogether

[IND Program CCTG @INDProgramCCTG]

MDICT 2024 recommendations for neoadjuvant early clinical trials now published. Led by ESMO-TAT chairs @lillian_siu @ElenaGarralda @AnastasiosStat2 and MDICT’24 team supported by @myESMO

https://t.co/RZdCpG0iWG

[CCTG @CDNCancerTrials]

#CCTG & @marathonofhope are excited to launch CAN-PREDICT-IT. The project aims to better predict which cancer patients will benefit from specific #immunotherapies by using large data sets from patients to identify significant biomarkers. #ClinicalTrials

https://t.co/kzlN1uvs4K

[CCTG @CDNCancerTrials]

#CCTG PR13 | RADICALS-RT : Men who have had prostate cancer surgery do not need immediate radiotherapy - long term results confirm no evidence of a benefit of radiotherapy soon after surgery #prostatecancer @MRCCTU @pmcancercentre @CRCHUM
Results: https://t.co/Ds4wqeuPQn

[Canadian Cancer Society @cancersociety]

An estimated 11,300 Canadians are expected to be diagnosed with melanoma this year.

That’s why we are proud to be uniting with a team of 12 researchers and collaborators to lead one of the world’s largest randomized clinical trials using fecal microbiota transplantation to improve the effectiveness of treatments for advanced melanoma.

▶️ Discover how this promising treatment has already changed the lives of people facing cancer.

Visit the link below to learn more.

https://t.co/rA1hVYC3uw

#MelanomaSkinCancerAwarenessMonth
#Melanoma

@CRCHUM
@chumontreal
@CDNCancerTrials
@JEDancey
@lawsonresearch

[CCTG @CDNCancerTrials]

“These results are important because they demonstrate for the first time that a simple hysterectomy is a safe option for women with carefully selected low-risk early-stage cervical cancer”Dr. Marie Plante
@chudequebec @cordekroon @LUMC @DrLoriBrotto @ArcagyGineco @UBCmedicine

[André Picard @picardonhealth]

Canada needs a national system for #cancer clinical trials. Currently, clinical trials are underfunded, inefficient and burdened by excessive regulation, by @JEDancey of @CDNCancerTrials https://t.co/z5o7v3YF0E via @torontostar @janephilpott

[CCTG @CDNCancerTrials]

#CCTG IND227 trial results published in @TheLancet concludes that the addition of pembrolizumab to platinum–pemetrexed improved overall survival in patients with #pleural #mesothelioma
https://t.co/oRvkSNNRKM

[Alison Urton @UrtonAlison]

Congratulations and thank you Joe for all you have done for the research community and patients around the world! So grateful to continue to learn from you everyday @CDNCancerTrials You are the original #trialblazer

[CCTG @CDNCancerTrials]

Dr. Joseph Pater #CCTG's founding director recognized for a lifetime of work in cancer research with his appointment as an Officer of the Order of Canada - his clinical research has improved the lives of Canadians with cancer. #OrderOfCanada #GGHonours 
https://t.co/QvTq1Fs6gm

[CCTG @CDNCancerTrials]

“The data presented today demonstrate that the use of pembrolizumab and platinum-pemetrexed chemotherapy extends the lives of patients with unresectable advanced or metastatic pleural mesothelioma,” said Dr Quincy Chu, #CCTG study chair for IND227 #solvingcancertogether

[Alison Urton @UrtonAlison]

Ready to go at #ASCO2023 Congratulations to all! @CDNCancerTrials @IFCTlung @istitutotumori @fperrone62

[IND Program CCTG @INDProgramCCTG]

Dr Quincy Chu, CCTG Chair IND.227 (with Dr Penny Bradbury (Lung Disease Site Chair) & Dr Janet Dancey, (CCTG Director)) will present results on behalf of co-chairs Drs Francesco Perrone & Laurent Greillier and investigators @CDNCancerTrials @IFCTlung @istitutotumori @fperrone62

[Glauco Baiocchi @glaucobaiocchi]

Happy to see in person Dr Plante presenting SHAPE trial. Huge impact for women with cervical cancer in a surgical trial! Congrats to all investigators!! @ASCO @IGCSociety @ESGO_society @SGO_org @acccancercenter @br_gynoncgroup

[Alison Urton @UrtonAlison]

With thanks to incredible international collaboration, very excited to hear Dr. Quincy Chu present the results today! @CNDCancerTrials @INDProgramCCTG #SolvingCancerTogether #ASCO2023

[IND Program CCTG @INDProgramCCTG]

Very excited to hear Dr. Quincy Chu from the Cross Cancer Institute present the results of this international academic trial this afternoon. A wonderful collaboration with our partners in Italy and France. @istitutotumori @AIOMtweet @IFCTlung @CDNCancerTrials @UHN @chumontreal